Month: April 2024

2065 posts
Infoblox Threat Intel Discovers Muddling Meerkat, a DNS Operation Controlling China's Great Firewall

Infoblox Threat Intel Discovers Muddling Meerkat, a DNS Operation Controlling China's Great Firewall

Muddling Meerkat utilizes sophisticated DNS activities, likely propagated by Chinese state actors, to…
CARsgen Submitted Responses to FDA Observations

CARsgen Submitted Responses to FDA Observations

SHANGHAI, April 29, 2024 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code:…
Laekna Releases 2023 ESG Report

Laekna Releases 2023 ESG Report

SHANGHAI and WARREN, N.J., April 29, 2024 /PRNewswire/ — Laekna, Inc. (2105.HK),…
Huawei Unveils GoPaint, a Brand-new Self-developed Painting App on May 7, Bringing the Fun of Creation to the Masses

Huawei Unveils GoPaint, a Brand-new Self-developed Painting App on May 7, Bringing the Fun of Creation to the Masses

SHENZHEN, China, April 29, 2024 /PRNewswire/ — Huawei will launch a new…
Microland announces Global Elite Plus Status with Juniper Networks to launch Network as a Service offering

Microland announces Global Elite Plus Status with Juniper Networks to launch Network as a Service offering

Microland will focus on building and launching a user experience-based Network as…
WOORI FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F

WOORI FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F

SEOUL, South Korea, April 29, 2024 /PRNewswire/ — On April 29, 2024, Woori…
Puerto San Antonio and Chile's Ministry of Transportation and Telecommunications held a successful meeting in Madrid with companies interested in building Puerto Exterior

Puerto San Antonio and Chile's Ministry of Transportation and Telecommunications held a successful meeting in Madrid with companies interested in building Puerto Exterior

SAN ANTONIO, Chile, April 29, 2024 /PRNewswire/ — The informative event organized…
Henlius Trastuzumab Receives FDA Approval in the United States

Henlius Trastuzumab Receives FDA Approval in the United States

SHANGHAI, April 29, 2024 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696.HK) announced that…